Stay updated on Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.

Latest updates to the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.5.2 was added to the history; Revision: v3.5.0 was removed from the history.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedRevision v3.5.0 was added and revision v3.4.3 was removed from the history.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.4.3 was added to the record history. Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision: v3.4.2 to the Record History; removed the funding-status notice and the previous Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check75 days agoChange DetectedAdded a government funding lapse notice and release version v3.4.1. Removed release version v3.4.0.SummaryDifference0.8%

- Check82 days agoChange Detected- The Record History page now displays a Show glossary option and uses color-coded diffs (green for additions, red for deletions). It also shows a revision tag of v3.4.0, replacing the previous v3.3.4 tag.SummaryDifference1%

Stay in the know with updates to Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab + Kd in Lenalidomide-Refractory Myeloma: Clinical Trial page.